Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Filings indexed 605 across all filing types
Latest filing 2019-09-06 Director's Dealing
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-09-06 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The key content is the announcement of the departure of the Chief Financial Officer and related management changes. There is no financial data or detailed report content, only a management change announcement and a press release. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3260 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2019-08-27 English
4
Director's Dealing
2019-08-22 English
10-Q
Interim / Quarterly Report Q2 2019
2019-08-14 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 14, 2019, reporting the results of operations and financial condition for the quarter ended June 30, 2019. It specifically states that the company issued a press release announcing its financial and operating results for that quarter, and the press release is furnished as an exhibit. The document itself is short (3507 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights only, not a full interim or annual report.
2019-08-14 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 24, 2019, reporting the entry into a material definitive agreement related to an underwriting agreement for a public offering of common stock. It details the terms of the offering, the use of proceeds, and includes exhibits such as the underwriting agreement, legal opinion, and press releases announcing the offering launch and pricing. The content focuses on financing activities and capital raising rather than financial results, management changes, or other report types. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2019-06-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.